PR3 Antibodies

Santa Cruz Biotechnology features a diverse variety of PR3 monoclonal antibodies for investigating proteinase 3 (PR3) in various biological processes. PR3 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Proteinase 3 is a serine protease primarily expressed in neutrophils and plays a crucial role in the immune response, particularly in the degradation of extracellular matrix components and the activation of other immune cells. PR3 dysregulation has been implicated in various inflammatory diseases and autoimmune disorders, making proteinase 3 a significant target for therapeutic intervention and biomarker discovery. Understanding proteinase 3 function is essential for elucidating its contributions to both normal physiology and pathological conditions. PR3 monoclonal antibodies enable precise detection and characterization of proteinase 3 expression patterns across different tissue types. Researchers can track proteinase 3 localization and interactions within cellular compartments using multiple experimental approaches. PR3 monoclonal antibodies from Santa Cruz Biotechnology support scientists worldwide in advancing our understanding of immune system regulation and disease mechanisms.